Cardio Diagnostics
CDIO
14 hedge funds and large institutions have $4.12M invested in Cardio Diagnostics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
2,607% more capital invested
Capital invested by funds: $152K → $4.12M (+$3.97M)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
4.24% more ownership
Funds ownership: 3.83% → 8.07% (+4.2%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.23M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$194K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$72.6K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$53.2K |
| 5 |
Squarepoint
New York
|
+$45.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Prelude Capital Management
New York
|
-$41.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$11K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.99K |
| 4 |
Renaissance Technologies
New York
|
-$6K |
| 5 |
HF
HRT Financial
New York
|
-$3K |
CDIO Hedge Fund Activity: Q4 2023 in Review
14 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q4 2023, worth a combined $4.12M — up 2,607% from $152K a quarter earlier.
Fund positioning in CDIO was balanced in Q4 2023: 5 funds opened new positions, 5 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $1.23M. The largest seller was Prelude Capital Management, exiting entirely with an estimated $41.1K sold.
- 14 institutional investors held Cardio Diagnostics (CDIO) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $4.12M of Cardio Diagnostics stock for Q4 2023, up 2,607% quarter-over-quarter.
- 5 funds opened new Cardio Diagnostics positions in Q4 2023 and 5 closed out, a net change of 0 holders.
- The largest Cardio Diagnostics buyer in Q4 2023 was BlackRock, an estimated $1.23M added.
- The largest Cardio Diagnostics seller in Q4 2023 was Prelude Capital Management, an estimated $41.1K sold.
Based on aggregated 13F filings for Q4 2023.